Telemedicine expert Tania Elliott, MD, available for interviews to discuss how to conduct telemedicine appointmentsAmerican College of Allergy, Asthma and Immunology (ACAAI)
Because COVID-19 attacks the lungs, limiting social contact is extremely important for people who have underlying health conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and any additional chronic lung illness.
There is no data to suggest that continuing allergy and asthma medications will have any effect on increasing your risk of getting the COVID-19 infection, or if you get the infection, lead to a worse outcome.
Certain areas of the country are experiencing shortages of albuterol inhalers. There are options for asthma sufferers who can't get an inhaler.
As the global pandemic continues and its impact increasingly disrupts daily life in the U.S., a new ongoing survey launched this week reveals specific concerns about the novel coronavirus among people living with chronic illnesses, who feel these conditions make them more susceptible to the virus (73%) and are beginning to turn to each other (58%) and their doctors (36%) for more information.
Finally, some good news has emerged about the novel coronavirus that has spread to about 50 countries across the world.
Melbourne researchers have mapped immune responses from one of Australia's first novel coronavirus (COVID-19) patients, showing the body's ability to fight the virus and recover from the infection.
COVID-19 is causing confusion and anxiety for many, including those with asthma. The American College of Allergy, Asthma and Immunology advises staying on your asthma medications to keep asthma under control.
University of Wisconsin–Madison researchers have identified a new way that common Aspergillus molds can induce asthma, by first attacking the protective tissue barrier deep in the lungs.
Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher risk of death from the new coronavirus (COVID-19), according to a new observational study of 191 patients with confirmed COVID-19 from two hospitals in Wuhan, China, published in The Lancet.